Clinical trial Recruiting at 1 site Observational Ages 18 and up

Self‑questionnaire to spot rare genetic bone conditions in adults with osteoporosis

Official title: Clinical Validation of a Self-questionnaire in Adults With Osteoporosis

Run by CHU de Quebec-Universite Laval · NCT07067827 · Data updated 2026-11-12

This project tests whether a self‑administered questionnaire can help identify rare genetic bone diseases in adults with osteoporosis.

More Osteoporosis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment58 (estimated)
SponsorCHU de Quebec-Universite Laval
Academic / other
Drugs / interventionsprednisone
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJuly 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 8, 2026
Trial IDNCT07067827 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with osteoporosis who are followed in the rheumatology or endocrinology clinics at CHU de Québec–Université Laval and who have internet access are the intended participants.

Probably not a fit

People who cannot consent or complete questionnaires, those with unknown family history (for example, adopted persons), or those without internet access are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare answers from a self‑administered questionnaire to information collected by telephone using a family tree to test the questionnaire's validity. Participants are adults with osteoporosis followed at CHU de Québec–Université Laval and will be randomized to complete either the questionnaire or the family‑tree interview first, with the other method repeated three months later. Clinical and sociodemographic data will be extracted from electronic medical records to describe participants and disease severity. The goal is to see how well the questionnaire matches the family‑tree information and to adapt it to improve accuracy for clinical screening.

Why it matters

Potential benefit: If successful, the questionnaire could make it easier to detect rare genetic bone diseases earlier and enable more personalized care for people with osteoporosis.

How similar studies have gone: Self‑reported family‑history questionnaires have been used in other genetic risk screenings with mixed accuracy, and this specific questionnaire is newly developed by the team and has not yet been validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult over 18
* Followed by the rheumatology or endocrinology clinics at the CHUL (CHU de Quebec-Universite Laval)
* Suffer from osteoporosis
* Have internet access

Exclusion Criteria:

* Unfit, unable to consent, unable to answer a questionnaire, unknown family history (e.g. adopted person)

Where it's running

  • CHU de Quebec-Universite Laval
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.